By Dr. Flávio H. BarbosaPublished October 31, 2026

Sleep apnea and cardiovascular health: what the evidence says

Obstructive sleep apnea (OSA) is characterized by repeated airway obstructions during sleep. These can cause intermittent drops in oxygen levels, fluctuations in the autonomic nervous system, and sleep fragmentation. The evidence indicates a relevant association with cardiovascular problems, but does not support the claim that every cardiac event is caused by apnea or that treating it eliminates the risk.

How apnea relates to the heart

The American Heart Association scientific statement describes an association between OSA and hypertension, atrial fibrillation, heart failure, coronary artery disease, pulmonary hypertension, and stroke. During obstructive episodes, the effort to breathe against a closed airway changes pressures within the chest; intermittent hypoxia and brief arousals also increase sympathetic activation. These mechanisms may contribute to increased blood pressure, cardiac strain, and heart rhythm disturbances.

Association is not synonymous with causation. Age, excess weight, and other conditions can simultaneously influence sleep and the cardiovascular system.

Signs and evaluation: what to look for

Habitual loud snoring, breathing pauses noticed by another person, nighttime choking, and daytime sleepiness are important signs. Morning headaches, nocturia, fragmented sleep, and difficulty concentrating may also occur. Evaluation warrants particular attention when there is difficult-to-control hypertension, recurrent atrial fibrillation, or a suspected breathing disorder in people with heart failure, as the AHA highlights.

Symptoms raise suspicion, but do not confirm the diagnosis. The Brazilian Society of Cardiology position statement emphasizes that clinical impression alone is insufficient. The American Academy of Sleep Medicine guideline for diagnostic testing recommends evaluation accompanied by polysomnography or, in adults without significant complicating conditions and with an appropriate risk profile, technically adequate home testing. In significant cardiorespiratory disease, polysomnography is preferred. Questionnaires help with screening, but do not replace testing indicated by a qualified professional.

What we know about treating apnea

Studies show a reduction in blood pressure in some patients, as well as improvements in snoring, sleepiness, and quality of life when treatment is effective and used as directed. However, the prevention of heart attack, stroke, or cardiovascular death remains more complex.

In the SAVE randomized clinical trial, involving 2,717 adults with moderate to severe OSA and established coronary or cerebrovascular disease, CPAP combined with usual care did not significantly reduce the composite of cardiovascular events over a mean follow-up of 3.7 years. There were improvements in sleepiness, snoring, quality of life, and mood. The result pertains to event prevention in that group and context, with average adherence of 3.3 hours per night; it does not, on its own, determine the indication for each individual. The SAVE study publication on PubMed helps interpret this limitation.

Frequently asked questions

Does sleep apnea cause heart attacks?

A direct relationship cannot be established for each individual. OSA is associated with cardiovascular risk factors and diseases, but individual risk depends on the overall clinical picture.

Should people with hypertension be evaluated for apnea?

Evaluation may be particularly relevant in resistant or poorly controlled hypertension, especially when snoring, breathing pauses, or sleepiness are present. The decision should be individualized.

If these signs are present, seek a Sleep Medicine evaluation. Do not use a questionnaire or online test for self-diagnosis, or change cardiovascular medications on your own. Individual evaluation allows OSA to be confirmed or ruled out and the result to be integrated into cardiovascular care.

Sources consulted

This content is educational and does not replace an individual medical evaluation.